Goldpoint Clinical Research — Indianapolis, Indiana

Goldpoint Clinical Research is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Goldpoint Clinical Research has participated in 10 clinical trials.

Therapeutic areas: Insomnia, Attention Deficit Hyperactivity Disorder, Excessive Sleepiness.

Sponsors: Sumitomo Pharma America, Inc., Cephalon, Mallinckrodt.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Goldpoint Clinical Research?

Goldpoint Clinical Research has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Goldpoint Clinical Research conducted?

Goldpoint Clinical Research has 10 clinical trials on record. Their work covers Insomnia, Attention Deficit Hyperactivity Disorder, Excessive Sleepiness.

Is Goldpoint Clinical Research accredited by Crixeo Health?

Yes — Goldpoint Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Goldpoint Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.